Clinical Trial

Improved Recovery of Walking in Acquired Muscle Weakness

Study acronym: Re-Walk-Easy
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of Re-Walk-Easy is to evaluate the effects of rehabilitation based on electrical stimulation on the motor performance of critically ill patients. The study will also investigate the pathophysiology of the two forms-the myopathic-predominant and the polyneuropathic-predominant variants-by examining the longitudinal progression of CIP and CIM and determining which form benefits more from electrical stimulation as a rehabilitative approach.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-15.
Status change: Not Yet Recruiting → Recruiting 2025-02-27
Trial Details
NCT Number NCT06786390
Lead Sponsor Fondazione Don Carlo Gnocchi ETS
Conditions Critical Illness Myopathy, Critical Illness Polyneuropathy
Enrollment 72 participants
Start Date 2025-02-25
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-03